Inamdar et al. reported that T2DM patients, who had higher average triglycerides than non-T2DM patients (1.90 vs. 1.27 mmol/L), showed greater carrier-noncarrier triglyceride differences for APOE ε2 (0.56 vs. 0.31) and ε4 (−0.45 vs. −0.12 mmol/L)78. The gene discussed is APOE; the disease is type 2 diabetes mellitus.